Case Study

How Temple Health Reduced Hypoglycemia by Over 70% with EndoTool SubQ

Discover the Impact of Patient-Specific Insulin Dosing at Temple Health's Jeanes Campus

The Customer

Temple Health, a prominent healthcare system in Philadelphia, PA, is renowned for providing high-quality patient care. This case study focuses on Jeanes Campus, a community hospital within the Temple Health network, where EndoTool SubQ was implemented to enhance glycemic control and reduce hypoglycemic events in ICU and post-operative patients.

Key Results

Hypoglycemia Reduction: Hypoglycemic events (glucose readings <70 mg/dL) decreased by over 70%, from 2.64% pre-EndoTool to 0.34% post-implementation.
Severe Hypoglycemia: A significant 85% reduction in severe hypoglycemia (glucose readings <40 mg/dL), from 1.14% pre-EndoTool to 0.11% post-implementation.
Improved Glycemic Control: Patients managed with EndoTool SubQ demonstrated better glycemic control with fewer fluctuations compared to those using traditional sliding scale insulin dosing.
Enhanced Clinician Confidence: Nurses reported increased confidence in insulin dosing, supported by comprehensive training and continuous support from the Monarch team.

Challenge

Before implementing EndoTool SubQ, Temple Health struggled with inconsistent glycemic control in ICU and post-operative patients, leading to elevated risks of both hypoglycemia and hyperglycemia. Traditional insulin dosing methods, such as the sliding scale, failed to provide the precision required for optimal patient care in these critical settings.

Solution

Following their implementation of EndoTool IV, Temple Health adopted EndoTool SubQ in 2024, a patient-specific insulin dosing system designed to provide individualized insulin recommendations based on a patient’s unique needs. The implementation included targeted clinician training and ongoing support from Monarch Medical Technologies to ensure a smooth transition and effective use of the system.

“I would emphasize for those contemplating improving their SubQ insulin management that you really have to look at your processes and educate to build confidence with clinicians. Then you’ll see the full benefits that EndoTool can deliver.”

Dr. David Fleece, MD

CMIO, Temple University Hospital

Conclusion

Clinical Improvements: The use of EndoTool SubQ significantly reduced mild and severe hypoglycemia rates and improved overall glycemic control.
Operational Efficiency: The system improved workflow efficiency, providing clinicians with real-time, data-driven insulin recommendations that reduced the need for manual adjustments and increased nurse confidence.
System-wide Expansion: Due to the success at Jeanes Campus, Temple Health plans to expand the use of EndoTool SubQ across additional hospitals in their network, reinforcing their commitment to patient-specific insulin dosing.

Source

This case study was adapted from a webinar presented by Dr. David Fleece, Chief Medical Information Officer at Temple Health, titled “Why Every Health System Should Use Patient-Specific Insulin Dosing Software.”

Year

2024